Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is April 18, 2024.
All times in Eastern Daylight Time.
-
Riassunto: Denis Johnson si unisce a Kindeva Drug Delivery come Direttore operativo per guidare le operazioni globaliWOODBURY, Minnesota e ST. LOUIS--(BUSINESS WIRE)--Kindeva Drug Delivery (Kindeva), una delle principali società internazionali nello sviluppo di prodotti combinati farmaco-dispositivo, oggi ha annu... more »
-
Denis Johnson rejoint Kindeva Drug Delivery comme COO pour diriger les opérations mondialesWOODBURY, Minnesota et SAINT-LOUIS--(BUSINESS WIRE)--Kindeva Drug Delivery (Kindeva), leader mondial des produits mixtes médicaments-dispositifs, a annoncé aujourd'hui que Denis Johnson a rejoint l... more »
-
Denis Johnson wird Chief Operating Officer bei Kindeva Drug Delivery und leitet das weltweite operative GeschäftWOODBURY, Minn. & ST. LOUIS--(BUSINESS WIRE)--Kindeva Drug Delivery (Kindeva), ein weltweit führender Anbieter von Kombinationsprodukten aus Medikamenten und Geräten, hat heute bekannt gegeben, das... more »
-
HOUSTON--(BUSINESS WIRE)--Mesa Royalty Trust (the “Trust”) (NYSE: MTR) announced today the Trust income distribution for the month of April 2024. Unitholders of record on April 30, 2024 will receiv... more »
-
LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation (NASDAQ:NRC) today announced that it will provide an online web simulcast of its 2024 first quarter earnings conference call on Wednesd... more »
-
AUSTIN, Texas--(BUSINESS WIRE)--CS Disco, Inc. (“DISCO”) (NYSE: LAW), a leader in AI-enabled legal technology, today announced that it will report its financial results for the first quarter ended ... more »
-
Western Alliance Bancorporation Reports First Quarter 2024 Financial ResultsPHOENIX--(BUSINESS WIRE)--Western Alliance Bancorporation Reports First Quarter 2024 Financial Results more »
-
ROCKLAND, Mass.--(BUSINESS WIRE)--Independent Bank Corp. (Nasdaq Global Select Market: INDB), parent of Rockland Trust Company, today announced 2024 first quarter net income of $47.8 million, or $1... more »
-
DermTech to Explore Strategic Alternatives and Implement Restructuring PlanSAN DIEGO--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced that the s... more »
-
Primoris Services Corporation Schedules First Quarter 2024 Earnings Conference Call and WebcastDALLAS--(BUSINESS WIRE)--Primoris Services Corporation (NYSE: PRIM) (“Primoris” or the “Company”) today announced it will report first quarter 2024 financial results on Wednesday, May 8, 2024, afte... more »
-
HOUSTON--(BUSINESS WIRE)--VOC Energy Trust (NYSE: VOC) announced the Trust distribution of net profits for the first quarterly payment period ended March 31, 2024. Unitholders of record on April 30... more »
-
Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial ResultsLOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology will issue it's 1Q-2024 results after the close on May 2, 2024, and host a conference call to discuss results at 1:30 p.m. PDT. more »
-
Xylem to Host Investor Day on May 30, 2024WASHINGTON--(BUSINESS WIRE)--Xylem to Host Investor Day on May 30, 2024 more »
-
The GEO Group Closes Senior Notes Offering and New Term LoanBOCA RATON, Fla.--(BUSINESS WIRE)--The GEO Group (NYSE: GEO) (“GEO” or the “Company”) announced today that it has closed a private offering of $1.275 billion aggregate principal amount of senior no... more »
-
BRANFORD, Conn.--(BUSINESS WIRE)--Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announce... more »